期刊文献+

浙江地区汉族人TAFI基因编码序列C1040T基因多态性的研究

Study of C1040T Polymorphism of Thrombin Activatable Fibrinolysis Inhibitor Gene Coding Sequence in Zhejiang Han Population
下载PDF
导出
摘要 目的研究浙江地区汉族人凝血酶活化的纤溶抑制物基因编码区中与其血浆水平相关的C1040T基因多态性的特点。方法应用PCR技术结合SpeI酶切分析,研究了126名浙江地区汉族人凝血酶活化的纤溶抑制物基因编码区C1040T基因的多态性。结果浙江地区汉族人等位基因C1040与等位基因T1040的频率分别为0.798和0.202;基因型1040C/C纯合子、1040C/T杂合子及1040T/T纯合子的频率分别为0.667、0.262和0.071。结论浙江地区汉族人凝血酶活化的纤溶抑制物C1040T基因多态性的分布与其他人种有显著性差异。 Objective To investigate the C1040T polymorphism in thrombin activatable fibrinolysis inhibitor gene coding sequence in Zhejiang Han population, and this polymorphism was assiocated with the levels of thrombin activatable fibrinolysis inhibitor in plasma. Methods The C1040T polymorphism in TAFI from 126 no sib individuals was analyzed by polymerase chain reaction and Spe Ⅰ restriction assay, and the resulting products were electrophoresed in 1.5% agarose gels and stained with Gold View. Results In Zhejiang Han population, the allic frequencies were 0. 798 for C1040 allele and 0. 202 for T1040 allele. The genotype frequencies were 0. 667,0. 262 and 0. 071 for homozygous 1040C/C, heterozygous 1040C/T and homozygous 1040T/T, respectively. Conclusions The C1040T polymorphism of TAFI in Zhejiang Han population was significantly different from that in other population observed.
出处 《医学研究杂志》 2007年第5期34-36,共3页 Journal of Medical Research
基金 浙江省教育委员会科研基金资助项目(20030817) 温州市科技发展基金资助项目(Y2003A046)
关键词 凝血酶活化的纤溶抑制物 多态性 聚合酶链反应 限制性片段长度 Thrombin activatable fibrinolysis inhibitor Polymorphism Polymerase chain reaction Restriction fragment length
  • 相关文献

参考文献10

  • 1Bajzar L,Manuel R,Nesheim Me.Purification and characterization of TAFI,a thrombin activatable fibrinolysis inhibitor.J biol Chem,1995,270:14477-14484
  • 2Bonno N,Bouma,Pauline F,et al.Thrombin-activatable fibrinolysis inhibitor (TAFI,Plasma Procarboxypeptidase B,Procarboxypeptidase R,Procarboxypeptidase U).Throbosis Reseash,2001,101:329-3254
  • 3Chetaille P,Alessi MC,Kouassi D,et al.Plasma TAFI antigen variations in healthy subjects.Thromb Haemost,2000,83:902 -905
  • 4Brouwers GJ,Vos HL,et al.A novel,possibly functional,single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels.Blood,2001,15 ;98(6):1992-1993
  • 5Henry M,Aubert H,et al.Identification of polymorphisms in the promoter and the 3' region of the TAFI gene:evidence that plasma TAFI antigen levels are strongly genetically controlled.Blood,2001,1:97(7):2053 -2058
  • 6Hiroyasu A,Hidehisa Y,Yusen C,et al.TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction.British Journal of Haematology,2004,127:440-447
  • 7Morange PE,Henry M,et al.Thr325Ⅱe polymorphism of the TAFI gene does not influence the risk of myocardial infection.Blood,2002,1:99(5):1878-1879
  • 8Leebeek FWG,van Goor MPJ,Guimaraes AHC,et al.High functional levels of thrombin activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke.Journal of Thrombosis and Haemostasis,2004,3:2211-2218
  • 9Nagashima M,Werner M,Wang M,et al.An inhibitor of activated thrombin activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator induced thrombolysis in a rabbit jugular vein thrombolysis model.Thromb Res,2000,98:333-342
  • 10Bjorkman JA,Abrahamsson TI,N VK,et al.Inhibition of boxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.Thromb Res,2005,116:519-524

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部